InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by GERAGHTY JAMES A, Directeur. Insider active across 1 companies, notably Fulcrum Therapeutics, Inc.. Cumulatively, 2 disclosures have been logged. Total volume traded: €154k. The latest transaction was disclosed on 28 June 2021 — Acquisition. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
€76,78810,000 shares@ €7.67880.017% mcap100.0% of flow
Common Stock
SEC:0000899243-21-026552·
Ideal exit: 25 Mar 2022 (T+270)
€76,78810,000 shares@ €7.67880.017% mcap50.0% of flow
Common Stock
SEC:0000899243-21-026552:0·
Ideal exit: 25 Mar 2022 (T+270)
2 of 2 declarations
About GERAGHTY JAMES A
James A. Geraghty is a Director at Fulcrum Therapeutics, Inc. He plays a key role in the governance of the company, bringing his experience to strengthen its strategy.
